The Tessa Jowell Brain Cancer Mission are pleased to announce that pre-applications for the next Brain Tumour Research Novel Therapeutics Accelerator (BTR-NTA) review cycle are now open!
The BTR-NTA is an international accelerator programme providing independent expert guidance to de-risk therapeutic development through systematic evaluation. The BTR-NTA welcomes applications from academic and industry researchers developing any type of therapeutic (including delivery platforms and devices) for patients with a brain tumour. As part of the BTR-NTA review, you could receive up to 240 hours of expert input from an international, multidisciplinary committee. Thanks to funding from Brain Tumour Research, the BTR-NTA programme is free for academic applicants and available at a nominal cost for industry applicants.
- To read more about the BTR-NTA programme and download the pre-application form, please visit the BTR-NTA website: https://www.tessajowellbraincancermission.org/strategic-programmes/btr-nta/
- To discuss how your therapy for brain tumours could benefit from a BTR-NTA review, please email Dr Charlotte Aitken to set up a brief call: charlotte.aitken@tessajowellbcm.org
Pre-applications will close on Friday 26th July 2024.